IDEXX Laboratories Stock (NASDAQ:IDXX)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$556.94

52W Range

$506.91 - $769.98

50D Avg

$563.17

200D Avg

$634.54

Market Cap

$44.01B

Avg Vol (3M)

$579.34K

Beta

1.54

Div Yield

-

IDXX Company Profile


IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.

Show More

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

11,000

IPO Date

Jun 21, 1991

Website

IDXX Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 23
Product$2.54B$2.25B$2.09B
Service$1.76B$1.65B$1.57B

Fiscal year ends in Dec 25 | Currency in USD

IDXX Financial Summary


Dec 25Dec 24Dec 23
Revenue$4.30B$3.90B$3.66B
Operating Income$1.36B$1.13B$1.10B
Net Income$1.06B$887.87M$845.04M
EBITDA$1.47B$1.28B$1.22B
Basic EPS$13.17$10.77$10.17
Diluted EPS$13.08$10.67$10.06

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 05, 26 | 12:00 AM
Q4 25Feb 02, 26 | 8:30 AM
Q3 25Nov 03, 25 | 8:30 AM

Peer Comparison


TickerCompany
ALNYAlnylam Pharmaceuticals, Inc.
EWEdwards Lifesciences Corporation
CORCencora, Inc.
CAHCardinal Health, Inc.
BDXBecton, Dickinson and Company
VEEVVeeva Systems Inc.
ZTSZoetis Inc.
ARGXargenx SE
IQVIQVIA Holdings Inc.
AAgilent Technologies, Inc.